{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:41:11Z","timestamp":1781739671738,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH114648"],"award-info":[{"award-number":["R01MH114648"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["South African National HIV Think Tank"],"award-info":[{"award-number":["South African National HIV Think Tank"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Behav Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In Southern and Eastern Africa, initiation of daily oral pre-exposure prophylaxis (PrEP) for HIV prevention has been high among adolescent girls and young women (AGYW) offered PrEP. However, persistence and prevention-effective use of PrEP among this critical group continues to be a challenge. We conducted a qualitative sub-study of AGYW from the Community PrEP Study in Eastern Cape Province, South Africa who had high rates of pick up for monthly PrEP refills over two years, but differing levels of PrEP adherence based on tenofovir-diphosphate (TFV-DP) measurements in dried blood spots (DBS). Contrasting 22 AGYW with low versus high levels of TFV-DP in DBS, we qualitatively explored factors which influenced PrEP persistence vs. non-persistence, unique patterns of PrEP use (e.g., discarding or stockpiling), and participant recommendations for improving AGYW prevention-effective use of PrEP in the future. Results showed that PrEP misconceptions and mistrust among participants\u2019 social networks negatively influenced adherence. In comparison, supportive families and\/or partners and personal trust that PrEP works positively influenced adherence. Those with low adherence described being motivated to come to the site for other study benefits (e.g., reimbursement money, snacks, sanitary pads) and discarding PrEP to avoid stigma associated with being seen with pills. Future PrEP implementation strategies should focus on involving families and partners in PrEP support for AGYW and minimizing PrEP stigma at a community level.<\/jats:p><jats:p><jats:italic>Trial registration<\/jats:italic> NCT03977181. Retrospectively registered on June 6, 2019.<\/jats:p>","DOI":"10.1007\/s10865-023-00462-2","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T19:02:26Z","timestamp":1702321346000},"page":"320-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa"],"prefix":"10.1007","volume":"47","author":[{"given":"Emily","family":"Krogstad Mudzingwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millicent","family":"Atujuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Fynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matinatsa","family":"Mugore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selly","family":"Mabandla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybil","family":"Hosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Celum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-4141","authenticated-orcid":false,"given":"Andrew","family":"Medina-Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"462_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01710-17","volume":"62","author":"PL Anderson","year":"2018","unstructured":"Anderson, P. L., Liu, A. Y., Castillo-Mancilla, J. R., Gardner, E. M., Seifert, S. M., McHugh, C., Wagner, T., Campbell, K., Morrow, M., Ibrahim, M., & Buchbinder, S. (2018). Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrobial Agents and Chemotherapy, 62, 10\u20131128.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"462_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s13063-021-05402-6","volume":"22","author":"A Medina-Marino","year":"2021","unstructured":"Medina-Marino, A., Bezuidenhout, D., Hosek, S., Barnabas, R. V., Atujuna, M., Bezuidenhout, C., Ngwepe, P., Peters, R. P. H., Little, F., Celum, C. L., Daniels, J., & Bekker, L. G. (2021). The Community PrEP Study: A randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa\u2014study protocol. Trials, 22, 489. https:\/\/doi.org\/10.1186\/s13063-021-05402-6","journal-title":"Trials"},{"key":"462_CR3","doi-asserted-by":"publisher","first-page":"e0000636","DOI":"10.1371\/journal.pgph.0000636","volume":"3","author":"J Daniels","year":"2023","unstructured":"Daniels, J., De Vos, L., Bezuidenhout, D., Atujuna, M., Celum, C., Hosek, S., Bekker, L. G., & Medina-Marino, A. (2023). \u201cI know why I am taking this pill\u201d: Young women navigation of disclosure and support for PrEP uptake and adherence in Eastern Cape Province, South Africa. PLOS Global Public Health, 3, e0000636. https:\/\/doi.org\/10.1371\/journal.pgph.0000636","journal-title":"PLOS Global Public Health"},{"key":"462_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25968","author":"A Medina-Marino","year":"2022","unstructured":"Medina\u2010Marino, A., Bezuidenhout, D., Ngwepe, P., Bezuidenhout, C., Facente, S. N., Mabandla, S., Hosek, S., Little, F., Celum, C. L., & Bekker, L. (2022). Acceptability and feasibility of leveraging community\u2010based HIV counselling and testing platforms for same\u2010day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa. Journal of the International AIDS Society. https:\/\/doi.org\/10.1002\/jia2.25968","journal-title":"Journal of the International AIDS Society"},{"key":"462_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03702-9","author":"EK Mudzingwa","year":"2022","unstructured":"Mudzingwa, E. K., De Vos, L., Atujuna, M., Fynn, L., Mugore, M., Hosek, S., Celum, C., Bekker, L. G., Daniels, J., & Medina-Marino, A. (2022). Factors influencing adolescent girls and young women\u2019s uptake of community-based PrEP services following home-based HIV testing in Eastern Cape, South Africa: A qualitative study. AIDS and Behavior. https:\/\/doi.org\/10.1007\/s10461-022-03702-9","journal-title":"AIDS and Behavior"},{"key":"462_CR6","doi-asserted-by":"publisher","first-page":"e25875","DOI":"10.1002\/jia2.25875","volume":"25","author":"E Mudimu","year":"2022","unstructured":"Mudimu, E., Sardinia, J., Momin, S., Medina\u2010Marino, A., Bezuidenhout, C., Bekker, L., Barnabas, R. V., & Peebles, K. (2022). Incremental costs of integrated PrEP provision and effective use counselling in community\u2010based platforms for adolescent girls and young women in South Africa: An observational study. Journal of the International AIDS Society, 25, e25875. https:\/\/doi.org\/10.1002\/jia2.25875","journal-title":"Journal of the International AIDS Society"},{"key":"462_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kakia, A., Odoyo, J., \u2026 Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367, 399\u2013410. https:\/\/doi.org\/10.1056\/NEJMoa1108524","journal-title":"New England Journal of Medicine"},{"key":"462_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25636","author":"CL Celum","year":"2020","unstructured":"Celum, C. L., Gill, K., Morton, J. F., Stein, G., Myers, L., Thomas, K. K., McConnell, M., van der Straten, A., Baeten, J. M., Duyver, M., Mendel, E., Naidoo, K., Dallimore, J., Wiesner, L., & Bekker, L.-G. (2020). Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: A randomized trial. Journal of the International AIDS Society. https:\/\/doi.org\/10.1002\/jia2.25636","journal-title":"Journal of the International AIDS Society"},{"key":"462_CR9","doi-asserted-by":"publisher","first-page":"e1003670","DOI":"10.1371\/journal.pmed.1003670","volume":"18","author":"C Celum","year":"2021","unstructured":"Celum, C., Hosek, S., Tsholwana, M., Kassim, S., Mukaka, S., Dye, B. J., Pathak, S., Mgodi, N., Bekker, L.-G., Donnell, D. J., Wilson, E., Yuha, K., Anderson, P. L., Agyei, Y., Noble, H., Rose, S. M., Baeten, J. M., Fogel, J. M., Adeyeye, A., \u2026 Delany-Moretlwe, S. (2021). PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLOS Medicine, 18, e1003670. https:\/\/doi.org\/10.1371\/journal.pmed.1003670","journal-title":"PLOS Medicine"},{"key":"462_CR10","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., & Chuachoowong, R. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381, 2083\u20132090.","journal-title":"The Lancet"},{"key":"462_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/QAI.0000000000000158","volume":"66","author":"AL Corneli","year":"2014","unstructured":"Corneli, A. L., Deese, J., Wang, M., Taylor, D., Ahmed, K., Agot, K., Lombaard, J., Manongi, R., Kapiga, S., Kashuba, A., & Van Damme, L. (2014). FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 66, 324\u2013331. https:\/\/doi.org\/10.1097\/QAI.0000000000000158","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"462_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/QAI.0000000000000525","volume":"68","author":"AL Corneli","year":"2015","unstructured":"Corneli, A. L., McKenna, K., Perry, B., Ahmed, K., Agot, K., Malamatsho, F., Skhosana, J., Odhiambo, J., & Van Damme, L. (2015). The science of being a study participant: FEM-PrEP participants\u2019 explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68, 578\u2013584. https:\/\/doi.org\/10.1097\/QAI.0000000000000525","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"462_CR13","unstructured":"Dedoose Version 9.0.46, web application for managing, analyzing, and presenting qualitative and mixed method research data. [Internet]. Los Angeles, CA: SocioCultural Research Consultants, LLC; 2022. Available from: www.dedoose.com"},{"key":"#cr-split#-462_CR14.1","unstructured":"Delaney-Moretlwe, S., Chersich, M., Harvey, S., Stangl, A., Baron, D., Columbini, M., Scorgie, N., Naicker., & Kapiga, S. (2018). Empowerment clubs did not increase PrEP continuation among adolescent girls and young women in South Africa and Tanzania - Results from the EMPOWER randomised trial. Amsterdam"},{"key":"#cr-split#-462_CR14.2","unstructured":"2018 [cited 2022 Jun 14]. Available from: https:\/\/programme.aids2018.org\/Abstract\/Abstract\/13449"},{"key":"462_CR15","unstructured":"Eastern Cape Socio Economic Consultative Council. Buffalo City Metro Municipality Socio Economic Review and Outlook, 2017. [Internet]. 2017 Apr. Available from: https:\/\/www.ecsecc.org\/documentrepository\/informationcentre\/buffalo-city-metro-municipality_44557.pdf"},{"key":"462_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11904-008-0028-y","volume":"5","author":"JD Fisher","year":"2008","unstructured":"Fisher, J. D., Amico, K. R., Fisher, W. A., & Harman, J. J. (2008). The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Current HIV\/AIDS Reports, 5, 193\u2013203.","journal-title":"Current HIV\/AIDS Reports"},{"key":"462_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1037\/0278-6133.25.4.462","volume":"25","author":"JD Fisher","year":"2006","unstructured":"Fisher, J. D., Fisher, W. A., Amico, K. R., & Harman, J. J. (2006). An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology, 25, 462\u2013473.","journal-title":"Health Psychology"},{"key":"462_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2352-4642(20)30248-0","volume":"4","author":"K Gill","year":"2020","unstructured":"Gill, K., Johnson, L., Dietrich, J., Myer, L., Marcus, R., Wallace, M., Pidwell, T., Mendel, E., Fynn, L., Jones, K., Wiesner, L., Slack, C., Strode, A., Spiegel, H., Hosek, S., Rooney, J., Gray, G., & Bekker, L.-G. (2020). Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: An open-label single-arm phase 2 trial. The Lancet Child & Adolescent Health, 4, 875\u2013883.","journal-title":"The Lancet Child & Adolescent Health"},{"key":"462_CR19","doi-asserted-by":"publisher","first-page":"e0248307","DOI":"10.1371\/journal.pone.0248307","volume":"16","author":"D Giovenco","year":"2021","unstructured":"Giovenco, D., Gill, K., Fynn, L., Duyver, M., O\u2019Rourke, S., van der Straten, A., Morton, J. F., Celum, C. L., & Bekker, L.-G. (2021). Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence. PLoS ONE, 16, e0248307. https:\/\/doi.org\/10.1371\/journal.pone.0248307","journal-title":"PLoS ONE"},{"key":"462_CR20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant, R. M., Anderson, P. L., McMahan, V., Albert Liu, K., Amico, R., Mehrotra, M., Hosek, S., Mosquera, C., Casapia, M., Montoya, O., Buchbinder, S., Veloso, V. G., Mayer, K., Chariyalertsak, S., Bekker, L.-G., Kallas, E. G., Schechter, M., Guanira, J., Bushman, L., \u2026 Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. The Lancet Infectious Diseases, 14, 820\u2013829. https:\/\/doi.org\/10.1016\/S1473-3099(14)70847-3","journal-title":"The Lancet Infectious Diseases"},{"key":"462_CR21","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casap\u00eda, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., & Montoya-Herrera, O. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363, 2587\u20132599.","journal-title":"New England Journal of Medicine"},{"key":"462_CR22","doi-asserted-by":"publisher","first-page":"232595821983101","DOI":"10.1177\/2325958219831011","volume":"18","author":"JE Haberer","year":"2019","unstructured":"Haberer, J. E., Mugo, N., Baeten, J. M., Pyra, M., Bukusi, E., & Bekker, L.-G. (2019). PrEP as a lifestyle and investment for adolescent girls and young women in Sub-Saharan Africa. Journal of the International Association of Providers of AIDS Care, 18, 232595821983101.","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"key":"462_CR23","unstructured":"Johnson, L., & Dorrington, R. (2022). Thembisa Model Version 4.5: Age-specific national and provincal model outputs. [Internet]. Cape Town, South Africa: University of Cape Town; 2022 Apr. Available from: https:\/\/www.thembisa.org\/downloads"},{"key":"462_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4102\/sajhivmed.v18i1.694","volume":"18","author":"LF Johnson","year":"2017","unstructured":"Johnson, L. F., Dorrington, R. E., & Moolla, H. (2017). Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa. South Afr J HIV Med., 18, 694.","journal-title":"South Afr J HIV Med."},{"key":"462_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., Hendrix, C. W., Dai, J. Y., Ganesh, S., Mkhize, B., Taljaard, M., Parikh, U. M., Piper, J., M\u00e2sse, B., Grossman, C., \u2026 Mike Chirenje, Z. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372, 509\u2013518. https:\/\/doi.org\/10.1056\/NEJMoa1402269","journal-title":"New England Journal of Medicine"},{"key":"462_CR26","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s10461-020-03145-0","volume":"25","author":"S O\u2019Rourke","year":"2021","unstructured":"O\u2019Rourke, S., Hartmann, M., Myers, L., Lawrence, N., Gill, K., Morton, J. F., Celum, C. L., Bekker, L. G., & van der Straten, A. (2021). The PrEP journey: understanding how internal drivers and external circumstances impact The PrEP trajectory of adolescent girls and young women in Cape Town, South Africa. AIDS and Behavior, 25, 2154\u20132165.","journal-title":"AIDS and Behavior"},{"key":"462_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","volume":"21","author":"K Rivet Amico","year":"2017","unstructured":"Rivet Amico, K., Wallace, M., Bekker, L.-G., Roux, S., Atujuna, M., Sebastian, E., Dye, B. J., Elharrar, V., & Grant, R. M. (2017). Experiences with HPTN 067\/ADAPT study-provided open-label PrEP among women in cape town: Facilitators and barriers within a mutuality framework. AIDS and Behavior, 21, 1361\u20131375. https:\/\/doi.org\/10.1007\/s10461-016-1458-y","journal-title":"AIDS and Behavior"},{"key":"462_CR28","doi-asserted-by":"publisher","first-page":"e0258542","DOI":"10.1371\/journal.pone.0258542","volume":"16","author":"E Rousseau","year":"2021","unstructured":"Rousseau, E., Katz, A. W. K., O\u2019Rourke, S., Bekker, L.-G., Delany-Moretlwe, S., Bukusi, E., Travill, D., Omollo, V., Morton, J. F., O\u2019Malley, G., Haberer, J. E., Heffron, R., Johnson, R., Celum, C., Baeten, J. M., & van der Straten, A. (2021). Adolescent girls and young women\u2019s PrEP-user journey during an implementation science study in South Africa and Kenya. PLoS ONE, 16, e0258542. https:\/\/doi.org\/10.1371\/journal.pone.0258542","journal-title":"PLoS ONE"},{"key":"#cr-split#-462_CR29.1","unstructured":"Simbayi, L. C. Z. K., Zuma, K., Zungu, N., Moyo, S., Marinda, E., Jooste, S., Mabaso, M., Ramlagan, S., North, A., Van Zyl, J., & Mohlabane, N. (2019). South African national HIV prevalence, incidence, behaviour and communication survey, 2017 [Internet]. Cape Town: HSRC Press"},{"key":"#cr-split#-462_CR29.2","unstructured":"2019 [cited 2022 Oct 19]. Available from: https:\/\/repository.hsrc.ac.za\/handle\/20.500.11910\/15052"},{"key":"462_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/01459740.2015.1116528","volume":"35","author":"J Stadler","year":"2016","unstructured":"Stadler, J., Scorgie, F., van der Straten, A., & Saethre, E. (2016). Adherence and the Lie in a HIV Prevention Clinical Trial. Medical Anthropology., 35, 503\u2013516.","journal-title":"Medical Anthropology."},{"key":"462_CR31","unstructured":"StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021."},{"key":"462_CR32","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1007\/s10461-020-03134-3","volume":"25","author":"MC Stoner","year":"2021","unstructured":"Stoner, M. C., Rucinski, K. B., Giovenco, D., Gill, K., Morton, J. F., Bekker, L. G., Celum, C. L., & van der Straten, A. (2021). Trajectories of PrEP adherence among young women aged 16 to 25 in Cape Town, South Africa. AIDS and Behavior, 25, 2046\u20132053.","journal-title":"AIDS and Behavior"},{"key":"462_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., & Mutanhaurwa, R. (2012). Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. New England Journal of Medicine, 367, 423\u2013434.","journal-title":"New England Journal of Medicine"},{"key":"462_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19, 349\u2013357.","journal-title":"International Journal for Quality in Health Care"},{"key":"462_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., & Temu, L. (2012). Preexposure Prophylaxis for HIV Infection among African Women. New England Journal of Medicine, 367, 411\u2013422.","journal-title":"New England Journal of Medicine"},{"key":"462_CR36","doi-asserted-by":"publisher","first-page":"e89118","DOI":"10.1371\/journal.pone.0089118","volume":"9","author":"A van der Straten","year":"2014","unstructured":"van der Straten, A., Stadler, J., Montgomery, E., Hartmann, M., Magazi, B., Mathebula, F., Schwartz, K., Laborde, N., & Soto-Torres, L. (2014). Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: The VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE, 9, e89118. https:\/\/doi.org\/10.1371\/journal.pone.0089118","journal-title":"PLoS ONE"},{"key":"462_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25463","author":"J Velloza","year":"2020","unstructured":"Velloza, J., Khoza, N., Scorgie, F., Chitukuta, M., Mutero, P., Mutiti, K., Mangxilana, N., Nobula, L., Bulterys, M. A., Atujuna, M., Hosek, S., Heffron, R., Bekker, L.-G., Mgodi, N., Chirenje, M., Celum, C., & Delany-Moretlwe, S. (2020). The influence of HIV\u2010related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: A qualitative study. Journal of the International AIDS Society. https:\/\/doi.org\/10.1002\/jia2.25463","journal-title":"Journal of the International AIDS Society"}],"container-title":["Journal of Behavioral Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10865-023-00462-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10865-023-00462-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10865-023-00462-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T12:10:18Z","timestamp":1710591018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10865-023-00462-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1007\/s10865-023-00462-2","relation":{},"ISSN":["0160-7715","1573-3521"],"issn-type":[{"value":"0160-7715","type":"print"},{"value":"1573-3521","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"17 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval for this research was obtained from the University of Cape Town Human Research and Ethics Committee (HREC 289\/2018). Separate approval was given by the Eastern Cape Provincial Department of Health to conduct the research in Eastern Cape Province. This study\u00a0involved human participants and all procedures were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}